ONE Bio Corp. (ONBI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2010 | 20.12 Million USD | 101.57% |
| 2009 | 9.98 Million USD | 28979.6% |
| 2008 | 34.33 Thousand USD | -91.05% |
| 2007 | 383.72 Thousand USD | 177.04% |
| 2006 | 138.5 Thousand USD | 0.07% |
| 2005 | 138.4 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2011 Q1 | 5.77 Million USD | -4.84% |
| 2011 Q3 | 5.75 Million USD | -5.19% |
| 2011 Q2 | 6.07 Million USD | 5.22% |
| 2010 Q4 | 6.06 Million USD | 20.81% |
| 2010 Q3 | 5.02 Million USD | 1.8% |
| 2010 FY | 20.12 Million USD | 101.57% |
| 2010 Q1 | 4.1 Million USD | -22.04% |
| 2010 Q2 | 4.93 Million USD | 20.06% |
| 2009 FY | 9.98 Million USD | 28979.6% |
| 2009 Q4 | 5.26 Million USD | 152.16% |
| 2009 Q3 | 2.08 Million USD | 325049.46% |
| 2009 Q1 | 2612.00 USD | -91.85% |
| 2009 Q2 | -643.00 USD | -124.62% |
| 2008 Q1 | 13.45 Thousand USD | -95.18% |
| 2008 FY | 34.33 Thousand USD | -91.05% |
| 2008 Q4 | 32.03 Thousand USD | 414.7% |
| 2008 Q2 | -975.00 USD | -107.25% |
| 2008 Q3 | -10.17 Thousand USD | -943.9% |
| 2007 FY | 383.72 Thousand USD | 177.04% |
| 2007 Q4 | 279.37 Thousand USD | 412.01% |
| 2007 Q1 | 22.49 Thousand USD | -52.95% |
| 2007 Q3 | 54.56 Thousand USD | 99.97% |
| 2007 Q2 | 27.28 Thousand USD | 21.31% |
| 2006 Q1 | 23.99 Thousand USD | 0.0% |
| 2006 Q2 | 20.57 Thousand USD | -14.23% |
| 2006 Q3 | 46.12 Thousand USD | 124.14% |
| 2006 Q4 | 47.8 Thousand USD | 3.65% |
| 2006 FY | 138.5 Thousand USD | 0.07% |
| 2005 FY | 138.4 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | -2439.00 USD | 825251.333% |
| Evofem Biosciences, Inc. | 11.7 Million USD | -71.924% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 6398.905% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 83.103% |
| Qrons Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 178.012% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 41802.98% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 16297.408% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | -34.179% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -648689.201% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | -105.487% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -30519.281% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 59032.477% |
| Mesoblast Limited | -35.16 Million USD | 157.227% |
| Marizyme, Inc. | 457.7 Thousand USD | -4297.062% |
| Genus plc | 178.7 Million USD | 88.738% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 90.856% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -32242.495% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -4806.67% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 183058.555% |
| ContraFect Corporation | -154 Thousand USD | 13168.468% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 40350.882% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -26118.315% |
| IMV Inc. | -962.29 Thousand USD | 2191.394% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 5293.649% |
| MultiCell Technologies, Inc. | 49.32 USD | -40805741.444% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 50.018% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | -41056.321% |
| Q BioMed Inc. | -8988.00 USD | 224014.564% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 28.772% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 130581.334% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 54.629% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 1862.959% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -28650.63% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 406510.359% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -14224.157% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 20738.303% |
| GB Sciences, Inc. | -624.00 USD | 3225330.929% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 23494.059% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 7.56 Billion USD | 99.734% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | -208.00 USD | 9675792.788% |
| Enzolytics Inc. | 30.7 Thousand USD | -65438.104% |
| Agentix Corp. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -4071.655% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.1 Billion USD | 98.184% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 4011.574% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -3159.793% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 95.086% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 227352.044% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 24102.005% |
| Kadimastem Ltd | -630.13 Thousand USD | 3293.815% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -1937.027% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | -109.4% |
| BioStem Technologies, Inc. | 15.42 Million USD | -30.474% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 170150.199% |
| Cell Source, Inc. | - USD | -Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -11298.641% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -11298.641% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | -1382.927% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 69498.072% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -4371.893% |
| SYBLEU INC | 11.69 Thousand USD | -171971.144% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -336.75% |
| Bioxytran, Inc. | -8285.00 USD | 243014.194% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 5495.561% |
| Neutra Corp. | 14.33 Thousand USD | -140293.729% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 24643.221% |
| PureTech Health plc | -1.6 Million USD | 1355.486% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 2110.06% |
| IXICO plc | 3.27 Million USD | -515.457% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 2999.919% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 1223.699% |
| CSL Limited | 7.7 Billion USD | 99.739% |
| Cellectis S.A. | 18 Thousand USD | -111708.006% |